Sign In
Buy PAHC
$30.53
-0.540 (-1.74%)
At Close: Jun 23, 2026
Here's Why Investors Should Buy Phibro (PAHC) Stock Now
08:56am, Wednesday, 20'th Mar 2024
Phibro's (PAHC) diversified offerings and prospering vaccine business buoy optimism for investors.
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
10:45am, Monday, 18'th Mar 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Why Is Phibro (PAHC) Up 12.7% Since Last Earnings Report?
12:36pm, Friday, 08'th Mar 2024
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Phibro (PAHC) Appears Well Poised on Launches, Vaccine Sales
12:06pm, Thursday, 07'th Mar 2024
Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
10:46am, Friday, 01'st Mar 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
04:00pm, Thursday, 29'th Feb 2024
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference. Chief Financial Officer, Glenn David a
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit
04:00pm, Wednesday, 14'th Feb 2024
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2024 Virtual Animal Health Summit. Chief Financial Officer, G
What Makes Phibro (PAHC) a New Buy Stock
01:01pm, Wednesday, 14'th Feb 2024
Phibro (PAHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
10:46am, Wednesday, 14'th Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript
03:55pm, Thursday, 08'th Feb 2024
Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript
Phibro (PAHC) Q2 Earnings and Revenues Top, Margins Down
08:31am, Thursday, 08'th Feb 2024
Phibro's (PAHC) fiscal 2024 second-quarter results reflect the strong performance of the Animal Health segment.
Phibro (PAHC) Reports Q2 Earnings: What Key Metrics Have to Say
09:01pm, Wednesday, 07'th Feb 2024
Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stree
Phibro Animal Health (PAHC) Surpasses Q2 Earnings and Revenue Estimates
07:31pm, Wednesday, 07'th Feb 2024
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.34 per share a year ago.
Why Is Phibro (PAHC) Up 13.6% Since Last Earnings Report?
12:48pm, Friday, 08'th Dec 2023
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Phibro Animal Health: Vaccine App And Analysts' Expectations Imply Undervaluation
08:53pm, Monday, 20'th Nov 2023
Phibro Animal Health Corporation is expected to experience net sales growth and net income growth in the coming years. The company has a healthy balance sheet with little debt, which positions it well
